Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ciprofloxacin intratympanic - ALK-Abello

Next Previous
Drug Profile

Ciprofloxacin intratympanic - ALK-Abello

Alternative Names: AuriPro™; Ciprofloxacin otic suspension - Otonomy; OTIPRIO; OTO-201

Latest Information Update: 04 Dec 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Otonomy
  • Developer Otonomy; Otonomy [CEASED]
  • Class Anti-infectives; Antibacterials; Carboxylic acids; Cyclopropanes; Fluoroquinolones; Piperazines; Small molecules; Urinary anti-infective agents
  • Mechanism of Action DNA gyrase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Otitis externa; Otitis media

Most Recent Events

  • 27 Sep 2021 No development reported - Phase-III for Otitis externa (In adolescents, In children, In the elderly, In infants, In adults) in Canada (Intratympanic)
  • 27 Sep 2021 No development reported - Phase-III for Otitis media (In adolescents, In children, In infants) in Canada (Intratympanic)
  • 03 Jun 2021 ALK Abello acquires Ciprofloxacin intratympanic from Otonomy

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top